How it works
How Prostacyl works: nine rows against the research
The front of the label reads Precision Prostate Support Blend. This page asks what each of the nine rows is supposed to be doing, honestly: which of them have a prostate literature behind them, which do not, and what the word precision can and cannot mean on a panel with four measurable shortfalls.
No mechanism is stated anywhere in the supplied material, and a supplement is not obliged to state one. What can be checked is each row against the literature on that ingredient. Six rows belong to the prostate literature: saw palmetto, pygeum, nettle root, pumpkin seed, lycopene and boron. Grape seed extract does not, and no reason for it is published. Two rows are vitamins, judged on whether their printed percentages are right.
What a supplement owes a reader, and what it does not
A concession first, because without it the rest of this page is unfair. A dietary supplement is under no obligation to publish a mechanism. It need not explain how it is supposed to work, it need not cite a study, and most products in this category do neither. A label that named its ingredients, gave their amounts and stopped would be a better document than most.
This label does exactly that, and more: it names the species, names the plant parts and standardises two rows. So the question this page asks is not “where is the mechanism?” It is the narrower and more useful one a reader actually has: given that every amount is printed, what is each amount likely to be doing? That question can only be asked of a label that prints amounts, which is why it has not been asked on most pages in this series.
One more boundary. The three claims on the front of the label are structure/function claims, and the FDA disclaimer is printed in full and in capitals beneath them, which is how the rule is meant to work. Of the three, Supports Healthy Prostate Size sits closest to the line, because an enlarged prostate is a disease state with a name, and the sales page for this product is reached at a URL ending /flow-warning/. That is a judgement FDA makes case by case rather than one a reader can settle from a label, and it is recorded as finding 18 rather than as a verdict here.
- U.S. Food and Drug Administration (2026). Structure/Function Claims for Dietary Supplements.
The nine rows, one at a time
Eight passes over the same panel. Each one asks the same question — what is this row supposed to be doing, and is there published work at a comparable dose — and answers it with the figure attached.
- 01Saw palmetto, 300 mg — the row with the most serious trial behind itThis is the ingredient the category is built on, and the ingredient with the most rigorous negative result against it. CAMUS randomised 369 men, escalated from 320 to 960 mg a day over 72 weeks, and found no difference from placebo at any dose: the AUA Symptom Index fell 2.20 points on saw palmetto and 2.99 on placebo. So the honest account of what this row is doing is: it is the ingredient a prostate formula is expected to contain, at an amount below the lowest arm of the trial that tested it most carefully, in a material whose standardisation is not printed.
- 02Pygeum, 200 mg standardised to 3% — a real literature, and a measurable shortfallPygeum bark has a clinical literature in benign prostatic hyperplasia, and that literature reports a standardisation: 13% total sterols, at about 100 mg a day. This row is doing the same job with 6.0 mg of phytosterols against the trial’s 13.0 mg. The job is the right job. The amount of the measured constituent is under half.
- 03Nettle, 50 mg of leaf — the right plant, the wrong partNettle belongs on a prostate panel, and the trials are specific about which part: Urtica dioica root, at 360 mg a day for six months as an aqueous extract. This row declares the leaf, whose own literature covers rheumatic complaints, osteoarthritis pain and allergic rhinitis. What this row is doing, then, is a different job from the one the prostate literature describes — and the label is the thing that tells you so.
- 04Pumpkin seed, 100 mg of Cucurbita moschata seed — a named material, uncostedPumpkin seed is one of the ingredients that belongs to this category rather than to general nutrition, and this label names the species and the part, which is better drafting than most. This desk is not going to print a trial dose beside it, because none appears in the sources listed at the foot of this page. So the row is neither one of the four shortfalls nor one this site can defend with a figure: it is 100 mg of a named material with no standardisation and no published dose cited here.
- 05Lycopene, 0.5 mg delivered — a plausible job at an implausible scaleLycopene has a prostate literature and a trial dose: 15 mg a day for 6 months in 40 men. What this row delivers is 0.5 mg, a thirtieth of it, because the 10 mg printed is 10 mg of a 5% preparation. The comparison that makes the scale clearest is not the trial but the grocery shelf: USDA puts one cup of canned tomato juice at 21.96 mg, about 44 times a day of this product.
- 06Boron, 10 mg — the sixth category ingredient, and the one with no dose to citeBoron is the sixth of the rows that belong to this category rather than to general nutrition, and it is the one of the six for which this desk has no trial dose to print. What can be stated is the safety arithmetic, and it is worth stating: no Daily Value has been established, the adult upper limit is 20 mg a day, and one serving is half of it — roughly 6.7 to 10 times a typical total daily intake of 1.0 to 1.5 mg. NIH records no adverse effects within the limit and no known clinically relevant drug interactions.
- 07Grape seed, 100 mg — the row with no account at allGrape seed extract is studied as an antioxidant and in cardiovascular contexts. It is not one of the ingredients the prostate literature is built on, and nothing in the merchant’s material says why it is in a Precision Prostate Support Blend. This is the one row of the nine where the question “what is this doing here?” has no answer in any supplied document. That is finding 9, and it is a gap in the explanation rather than a safety point.
- 08The two vitamins — nutrients, not botanicals, and judged differentlyVitamin E and vitamin B6 are not doing a botanical’s job and should not be read as though they were. They are nutrients with Daily Values, and the test for them is whether the percentage printed is the percentage delivered. B6 passes: 13.8 mg against a 1.7 mg Daily Value is 812%, correctly printed. Vitamin E does not: 167% is printed where the declared synthetic form delivers about 83%.
Count the outcomes. Six rows belong to the literature this product is sold against, and four of those six deliver substantially less of the measured constituent than the published work used. One row, boron, has a safety arithmetic but no dose this desk can cite. One row, grape seed, has no account at all. And two rows are vitamins, where one printed percentage is right and one is roughly double what the declared form delivers. Every row is set out in full here.
Saw palmetto against the trial that escalated and found nothing
This row deserves its own section, because the usual way of reading it is the wrong way. The usual reading is that 300 mg is a bit light. The trial says something more awkward than that.
The point of this scale is not that 300 mg is too little. It is that the trial which escalated to 960 mg a day across 369 men over 72 weeks found no difference from placebo at any of the three doses. This product sits below the lowest of them, and prints no standardisation, so it cannot even be placed on the same axis with confidence.
So the finding is not scale. It is that a trial of 369 men over 72 weeks, escalating to 960 mg a day, recorded a 2.20-point fall in the AUA Symptom Index on saw palmetto against 2.99 on placebo, P = .91, with no benefit on any secondary outcome. Taking more did not help the men in that trial. A product below the lowest arm is not short of a dose that worked; it is short of a dose that did not.
Underneath that sits the second problem, and it is the one the label could fix tomorrow. This row prints no standardisation. The trial extracts are lipidosterolic preparations standardised to a stated fatty-acid content; the phrase on the panel could describe several different materials. The label standardises the pygeum at 3% and the lycopene at 5% and leaves its largest botanical row unstandardised, which means the row cannot be placed on the axis above with confidence at all.
06Saw palmetto at 300 mg, below the lowest arm of the trial that found nothing
The row with no account
Eight of the nine rows can be given an account of some kind, even where the account ends in a shortfall. One cannot.
09Grape seed extract is on a prostate panel with no prostate rationale given
It is worth being precise about what this is and is not. It is not a safety finding: 100 mg of grape seed extract is not an alarming amount of anything. It is not an accusation of padding, because nothing supplied shows the intent behind the formula. What it is, is a gap in the explanation on a product whose selling word is precision. A reader who asks what each row is doing can get an answer for the rest of the panel and not for this one, and the merchant is the only party who could close that gap.
The same question, asked of the pumpkin seed row, gets a different and more comfortable answer: the ingredient belongs to this category, the species and part are named, and the reason no comparison appears on this site is that no trial dose for it is recorded in the sources at the foot of this page. An absent citation here is a limit on what this desk will claim, not a finding against the product.
What “precision” can and cannot mean here
The word is on the front of the label, so it is fair to ask what it is doing. It has no regulated meaning for a supplement, which means the only honest test is whether the product is precise about the things a reader can check. On one half of that test it does well, and the credit should come first.
| What precision could mean | What this label does | Earned? |
|---|---|---|
| Every ingredient carries its own stated amount | Nine rows, nine printed amounts, no proprietary blend, nothing behind a total. | Earned. This is the best disclosure in the series. |
| The material is identified precisely enough to look up | Five binomials and six plant parts printed, plus a named chemical form for both vitamins and the boron. | Largely earned. The nettle row prints the part but no binomial. |
| The measured constituent is quantified, not just the extract weight | Two rows of nine print a standardisation: pygeum at 3% and lycopene at 5%. | Partly. The largest botanical row, saw palmetto at 300 mg, prints none. |
| The amounts correspond to the doses the published work used | Lycopene delivers 0.5 mg against 15. Pygeum delivers 6.0 mg of sterols against 13.0. Nettle gives 50 mg of leaf against 360 mg of root. Saw palmetto sits below the lowest trial arm. | Not earned. Four rows of nine. |
| The printed percentages are the percentages delivered | B6 at 812% is correct. Vitamin E prints 167% for a synthetic form delivering about 83%. | One of two. An accuracy finding, not a safety one. |
| Every row has a stated reason for being there | Eight rows can be given an account. Grape seed extract cannot. | Not earned, on one row of nine. |
Read the right-hand column as a whole and the shape of this product comes out clearly. Precision of disclosure: yes, and more than any other label in this series. Precision of dose: no, on four rows out of nine. Those are different claims, and a reader who conflates them will buy on the strength of the first and receive the second. Everything this site does is an attempt to keep the two apart. The score and its reasoning are on the home page.
What can and cannot be said
What this page can state
- Every amount on the panel, because every amount is printed.
- That two rows print a standardisation, and what the multiplication of those two printed figures gives.
- That six rows belong to the prostate literature and one, grape seed extract, does not, with the merchant’s silence on that row recorded as finding 9.
- The published dose and standardisation for saw palmetto, pygeum, nettle root and lycopene, each with the source named.
- That the CAMUS trial escalated to 960 mg a day across 369 men and found no difference from placebo.
- That the printed B6 percentage is correct and the printed vitamin E percentage is roughly double what the declared form delivers.
- That a supplement is not obliged to publish a mechanism, and that this one does not.
What this page cannot state
- How the product works. No route is stated and none is required.
- That it does not work. Four rows below the published doses is not a trial result.
- A dose for the pumpkin seed row to be compared against, because none is cited in the sources at the foot of this page.
- What the saw palmetto is standardised to, because the label does not print it.
- Why grape seed extract is in the formula, because nothing supplied says.
- Whether the nine printed amounts are the nine amounts in the capsule, because no certificate of analysis was supplied.
- Anything about this product being adulterated. Nothing supplied suggests it, and this desk does not speculate.
The right-hand column is a list of questions the order desk can be asked, and two of them have short answers somebody at the company already knows: the saw palmetto standardisation, and the reason grape seed extract is on a prostate panel. The verification page has the full call script.
Questions people actually ask
Eight questions about how this product is supposed to work, phrased the way people type them. Type to filter.
prostacyl supplement does it work
Nothing supplied answers that, and this page will not pretend otherwise. No clinical trial of this product exists in the material and no document claims one. What can be done is to take each row to the literature on that ingredient, which is what this page does. Four of the nine rows land well short of the published doses, one row has no stated rationale at all, and the largest botanical row has the most careful negative trial in the category behind it.
how much saw palmetto for prostate per day
The trial that tested this most carefully used 320 mg a day, doubled to 640 at 24 weeks and tripled to 960 at 48, across 369 men over 72 weeks — and found no difference from placebo at any of the three. So the useful answer is not a number: it is that escalating the dose in that trial did not help. This product supplies 300 mg, below the lowest arm, with no standardisation printed.
saw palmetto 320 mg study results
CAMUS (Barry and colleagues, JAMA, 2011). Mean AUA Symptom Index fell 2.20 points on saw palmetto and 2.99 on placebo, P = .91, with no benefit on any secondary outcome and no difference at any of the three doses. The trial is the reason this desk treats the saw palmetto row as the one to read first, and the reason it does not treat 300 mg as merely too small.
what does precision prostate support blend mean
It is the product’s own description, printed on the front of the label. Blend is the interesting word, because on this label there is no proprietary blend: every ingredient carries its own printed amount. Precision has no regulated meaning. On the disclosure it is earned — nine amounts, two standardisations, species and parts. On the doses it is harder to defend, because four rows sit far below the published figures.
why is grape seed extract in a prostate supplement
Nothing in the supplied material says. Grape seed extract is studied as an antioxidant and in cardiovascular contexts, and it is not one of the ingredients the prostate literature is built on. It is 100 mg, the third-largest botanical row on the panel, and the only row of the nine for which no account of any kind is offered. That is finding 9.
how much lycopene per day prostate
The commonly cited trial used 15 mg a day for 6 months in 40 men. This product delivers 0.5 mg, because the 10 mg printed is a 5% preparation. For scale, USDA puts one cup of canned tomato juice at 21.96 mg and one cup of canned tomato puree at 54.39 mg.
prostate supplement instead of seeing a doctor
Urinary symptoms have causes worth identifying, and some of them need a clinician rather than a capsule. The label itself says it: the caution block tells anyone with a known medical condition to consult a physician before use. That instruction is printed on the product rather than buried on a sales page, and it is the single most useful sentence on the whole label. Who this is and is not for is set out here.
does prostacyl have a clinical trial
No trial of this product appears in any material supplied, and no document claims one. What exists is literature on individual ingredients at particular doses and standardisations, which is why this page compares row by row. A formula is not the sum of its citations, and a page that implied otherwise would be overclaiming in the opposite direction.
References
Every source below was opened and read. Each is cited on this page for a specific trial dose, standardisation convention, upper limit or food composition figure.
- National Institutes of Health, Office of Dietary Supplements (2026). Boron: Fact Sheet for Health Professionals.
- American Academy of Family Physicians (2012). Saw Palmetto Ineffective for Lower Urinary Tract Symptoms (Barry et al., JAMA 2011).
- PeaceHealth / Natural Medicines monograph (2026). Pygeum: dosage, standardisation to 13% total sterols, and evidence rating.
- Drugs.com natural products database (2026). Nettles (Urtica dioica): root doses used in BPH trials, and leaf uses.
- FoodNavigator, reporting Schwarz et al., Journal of Nutrition 138:49-53 (2008). Lycopene 15 mg a day for six months in 40 men with BPH.
- U.S. Department of Agriculture, National Agricultural Library (2026). Lycopene content of tomato products, per household measure.
- U.S. Food and Drug Administration (2026). Structure/Function Claims for Dietary Supplements.
Read the panel before you decide
Sixty capsules, two a day, thirty days a bottle. The Supplement Facts panel declares nine ingredients and nine amounts, with no proprietary blend — the most transparent label in this series. Four of those nine rows change meaning once the arithmetic is done, and all four sums are shown in full. One bottle is $69; six are $49 each. The refund window is printed as 60 days in one place and 90 in another.
- 60 or 90 days — the page prints both
- Nine ingredients, nine printed amounts, no blend
- Returns to 1370 Avenue of the Americas, Floor 4, New York, NY 10019, USA
Prices as printed on the sales page, as of October 12, 2026: one bottle $69, six bottles $49 each with free shipping. The three-bottle total is not published, so it is left blank rather than estimated. The refund window is printed as 60 days in one place and 90 in another — confirm it at the checkout. Questions first? Every published contact route is here.
Keep reading
Authorship and review
Who wrote and checked this page
What this page was checked against
- The label artwork, read at 2× and transcribed character for character. Where the label and the marketing disagree, the label is printed.
- The seller pack, quoted rather than paraphrased, and identified as marketing wherever it is used.
- The published sources listed in the references on this page. Every one was opened and read; none is cited from memory.
- The arithmetic, shown in full. Every amount on this panel is printed, so the figures here are conversions of printed amounts with the working given, never ceilings and never estimates.
- Nothing else. Any fact that was not supplied is recorded as not published rather than filled in.
Last updated October 12, 2026. A highlighted slot is a value no human has supplied yet. Who reviews these pages?